ASCL1 and small cell lung carcinoma: LSD1 inhibition downregulates ASCL1 and neuroendocrine differentiation in some SCLC cell lines and ASCL1 downregulation correlates with LSD1 inhibitor sensitivity in SCLC cell lines and PDX models7.